Mark Ballow Selected Research

Primary Immunodeficiency Diseases

8/2022	Precision Medicine in the Treatment of Primary Immune Deficiency Patients With Disorders of Immune Dysregulation.
1/2020	Nuts and Bolts of Subcutaneous Therapy.
1/2020	Diagnosis and management of Specific Antibody Deficiency.
1/2018	Precision medicine in the treatment of primary immunodeficiency diseases.
3/2017	Update on the use of immunoglobulin in human disease: A review of evidence.
1/2017	Specific Antibody Deficiency: Controversies in Diagnosis and Management.
1/2016	Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases.
11/2015	Immunoglobulin Replacement Therapy for Primary Immunodeficiency.
12/2013	Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: review of the current data.
1/2012	Considerations for the optimal use of immunoglobulin.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Ballow Research Topics

Disease

15	Primary Immunodeficiency Diseases 08/2022 - 05/2002
10	Infections 01/2022 - 05/2002
6	Asthma (Bronchial Asthma) 05/2010 - 11/2004
4	Autoimmune Diseases (Autoimmune Disease) 12/2014 - 12/2006
4	Hypersensitivity (Allergy) 05/2010 - 11/2004
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2012 - 05/2002
3	Nasal Polyps (Nasal Polyp) 03/2011 - 11/2003
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2017 - 08/2014
2	Bacterial Infections (Bacterial Infection) 11/2015 - 09/2007
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2012 - 08/2005
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2012 - 05/2002
2	Septic Shock (Toxic Shock Syndrome) 03/2011 - 11/2003
2	Inflammation (Inflammations) 03/2011 - 04/2010
2	Polyps 11/2003 - 01/2003
2	Sinusitis 11/2003 - 01/2003
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022
1	COVID-19 01/2021
1	Nijmegen Breakage Syndrome 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Plague (Bubonic Plague) 01/2018
1	Reinfection 01/2017
1	Lymphopenia (Lymphocytopenia) 08/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2014
1	Communicable Diseases (Infectious Diseases) 04/2014
1	Pneumonia (Pneumonitis) 12/2013
1	Foreign Bodies (Foreign Body) 01/2012
1	Polyneuropathies (Polyneuropathy) 01/2012
1	Immediate Hypersensitivity 03/2011
1	Purpura 02/2011
1	Thrombocytopenia (Thrombopenia) 02/2011
1	Rheumatoid Arthritis 04/2010
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2010
1	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 04/2008
1	Candidiasis (Moniliasis) 04/2008
1	Autoimmune Lymphoproliferative Syndrome 04/2008
1	Pruritus (Itching) 02/2008
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 02/2008
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2008
1	Abscess 01/2008
1	Nausea 09/2007
1	Headache (Headaches) 09/2007
1	Fatigue 09/2007
1	Myalgia 09/2007
1	Bruton type agammaglobulinemia 01/2007
1	Deficiency Diseases (Deficiency Disease) 08/2005
1	Virus Diseases (Viral Diseases) 05/2002
1	HIV Infections (HIV Infection) 05/2002
1	Guillain-Barre Syndrome 05/2002

Drug/Important Bio-Agent (IBA)

12	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 09/2007
8	Intravenous Immunoglobulins (IVIG)FDA Link 01/2016 - 05/2002
3	AntigensIBA 01/2020 - 04/2010
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2017 - 11/2003
3	Immunoglobulin G (IgG)IBA 01/2017 - 01/2012
3	CytokinesIBA 05/2004 - 01/2003
2	Pharmaceutical PreparationsIBA 01/2022 - 09/2007
2	Polysaccharides (Glycans)IBA 01/2020 - 01/2017
2	VaccinesIBA 08/2014 - 04/2014
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 04/2010
2	staphylococcal enterotoxin BIBA 03/2011 - 11/2003
2	Biological ProductsIBA 04/2010 - 12/2006
2	gamma-Globulins (gamma-Globulin)IBA 01/2007 - 05/2002
2	ChemokinesIBA 05/2004 - 01/2003
1	Interferon Type IIBA 01/2021
1	A-Form DNA (A-DNA)IBA 01/2020
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2017
1	Immunoglobulin A (IgA)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2014
1	CoagulaseIBA 03/2011
1	ExotoxinsIBA 03/2011
1	Staphylococcal enterotoxin AIBA 03/2011
1	Immunoglobulin E (IgE)IBA 03/2011
1	Monoclonal AntibodiesIBA 04/2010
1	Interleukin-2 Receptor alpha SubunitIBA 04/2008
1	AluminumIBA 01/2008
1	AllergensIBA 06/2007
1	Recombinant ProteinsIBA 12/2006
1	Methacholine Chloride (Methacholine)FDA Link 12/2006
1	cholest-8(14)-ene-3,26-diol-15-one (CEDO)IBA 11/2004
1	Interleukin-5 (Interleukin 5)IBA 05/2004
1	Interleukin-4 (Interleukin 4)IBA 05/2004
1	Interferon-gamma (Interferon, gamma)IBA 05/2004
1	Interleukin-2 (IL2)IBA 05/2004
1	SuperantigensIBA 11/2003
1	Enterotoxins (Enterotoxin)IBA 11/2003
1	CaprylatesIBA 09/2003

Therapy/Procedure

14	Therapeutics 01/2022 - 09/2003
2	Precision Medicine 08/2022 - 01/2018
2	Antibiotic Prophylaxis 01/2020 - 01/2017
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2012 - 05/2002
1	Transplantation 04/2014
1	Contact Lenses 02/2008
1	Premedication 09/2007
1	Intravenous Infusions 09/2007
1	Complementary Therapies (Alternative Medicine) 01/2007